Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1963 Oct;21(2):378–392. doi: 10.1111/j.1476-5381.1963.tb01536.x

The β-adrenergic blocking and pressor actions of isoprenaline in the cat

K R Butterworth
PMCID: PMC1703839  PMID: 14081668

Abstract

In the anaesthetized cat a single, large, intravenous dose of (—)-isoprenaline reversibly blocked the depressor properties of isoprenaline. Further large doses then caused monophasic rises in blood pressure, which were similar in rate of onset and duration to those produced by adrenaline and noradrenaline. This pressor effect was not due to an increase in cardiac output, but the main cause was vasoconstriction in skeletal muscle. The responses to isoprenaline, adrenaline and noradrenaline were compared, both before and after the blocking dose of isoprenaline. Isoprenaline prevented or antagonized the potentiation of the pressor effects of adrenaline and noradrenaline by cocaine. The pressor effect was blocked but not reversed by ergotamine and tolazine, which block sympathetic α-receptors. It is suggested that isoprenaline in large doses has two actions on the vascular system of the cat: a blockade of the sympathetic β-receptors and an excitation of α-receptors.

Full text

PDF
378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLACK J. W., STEPHENSON J. S. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet. 1962 Aug 18;2(7251):311–314. doi: 10.1016/s0140-6736(62)90103-4. [DOI] [PubMed] [Google Scholar]
  2. BOURA A. L., GREEN A. F. The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol Chemother. 1959 Dec;14:536–548. doi: 10.1111/j.1476-5381.1959.tb00961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BUTTERWORTH K. R. A vasopressor response to isoprenaline in the cat. Nature. 1963 Jun 1;198:897–898. doi: 10.1038/198897a0. [DOI] [PubMed] [Google Scholar]
  4. CRAWFORD T. B. B., OUTSCHOORN A. S. The quantitative separation of adrenaline and noradrenaline in biological fluids and tissue extracts. Br J Pharmacol Chemother. 1951 Mar;6(1):8–19. doi: 10.1111/j.1476-5381.1951.tb00614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FURCHGOTT R. F., BHADRAKOM S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther. 1953 Jun;108(2):129–143. [PubMed] [Google Scholar]
  6. HERMANN H., CHATONNET J., VIAL J. Sur quelques faits concernant les phénoménes d'inversion de l'adrénaline. J Physiol (Paris) 1954;46(1):384–386. [PubMed] [Google Scholar]
  7. HERMANSEN K. The effect of adrenaline, noradrenaline and isoprenaline on the guinea-pig uterus. Br J Pharmacol Chemother. 1961 Feb;16:116–128. doi: 10.1111/j.1476-5381.1961.tb00304.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HUIDOBRO F., CROXATTO R., ALLENDE J., DEL RIO J. Fundamental basis of the specificity of pressor and depressor amines in their vascular effects. I. Blockade of the hypertensive action of vasopressor amines by the effect of the same substances. Acta Physiol Lat Am. 1951 Feb;1(2):91–109. [PubMed] [Google Scholar]
  9. LANDS A. M., LUDUENA F. P., TULLAR B. F. The pharmacologic activity of the optical isomers of isopropylarterenol (isuprel) compared with that of the optically inactive analog 1-(3,4-dihydroxyphenyl)-2-isoprophylaminoethane HCI. J Pharmacol Exp Ther. 1954 Aug;111(4):469–474. [PubMed] [Google Scholar]
  10. LEVY B., AHLQUIST R. P. An analysis of adrenergic blocking activity. J Pharmacol Exp Ther. 1961 Aug;133:202–210. [PubMed] [Google Scholar]
  11. LUDUENA F. P. Smooth muscle contracting effects of levo-N-isopropl arterenol and adrenolytic action of its dextroisomer. Arch Int Pharmacodyn Ther. 1962 May 1;137:155–165. [PubMed] [Google Scholar]
  12. PLETSCHER A., SHORE P. A., BRODIE B. B. Serotonin release as a possible mechanism of reserpine action. Science. 1955 Aug 26;122(3165):374–375. doi: 10.1126/science.122.3165.374. [DOI] [PubMed] [Google Scholar]
  13. POWELL C. E., SLATER I. H. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol. J Pharmacol Exp Ther. 1958 Apr;122(4):480–488. [PubMed] [Google Scholar]
  14. ROBERTS M. A note on the use of cellulose phosphate cation-exchange paper for the separation of catecholamines, and some other biogenic amines. J Pharm Pharmacol. 1962 Nov;14:746–749. doi: 10.1111/j.2042-7158.1962.tb11170.x. [DOI] [PubMed] [Google Scholar]
  15. SHEPHERD D. M., WEST G. B. Noradrenaline and the suprarenal medulla. Br J Pharmacol Chemother. 1951 Dec;6(4):665–674. doi: 10.1111/j.1476-5381.1951.tb00678.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. VOGT M. The secretion of the denervated adrenal medulla of the cat. Br J Pharmacol Chemother. 1952 Jun;7(2):325–330. doi: 10.1111/j.1476-5381.1952.tb01329.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. WALZ D. T., KOPPANYI T., MAENGWYN-DAVIES G. D. Isoproterenol vasomotor reversal by sympathomimetic amines. J Pharmacol Exp Ther. 1960 Jun;129:200–207. [PubMed] [Google Scholar]
  18. WALZ D. T., MAENGWYN-DAVIES G. D. The mechanism of isoproterenol vasomotor reversal by phyenylephrine. J Pharmacol Exp Ther. 1960 Jun;129:208–213. [PubMed] [Google Scholar]
  19. WURZEL M., PRUSS T. P., KOPPANYI T., MAENGWYN-DAVIES G. D. Dichloroisoproterenol blockade of the rabbit aortic strip. Arch Int Pharmacodyn Ther. 1963 Jan 1;141:153–162. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES